Skip to content

Aevi Genomic Medicine, Inc.: filings

Every Aevi Genomic Medicine, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 34 filings, each linked to its SEC index.

Filing record ends 2019-11-14

The latest filing in this captured record is a 10-Q filed 2019-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-23. Aevi Genomic Medicine, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-11-14fiscal Q3 201921620001104659-19-063708
10-Q2019-08-13fiscal Q2 201920600001144204-19-039522
10-Q2019-05-14fiscal Q1 201923500001144204-19-025777
10-K2019-03-29fiscal FY 2018311260001144204-19-017064
10-Q2018-11-01fiscal Q3 201820520001144204-18-056629
10-Q2018-08-02fiscal Q2 201821540001144204-18-041536
10-Q2018-05-15fiscal Q1 201821440001144204-18-028408
10-K2018-03-13fiscal FY 2017311520001144204-18-014238
10-Q2017-11-02fiscal Q3 201723620001144204-17-055648
10-Q2017-08-09fiscal Q2 201719520001144204-17-041687
10-Q2017-05-10fiscal Q1 201717360001144204-17-025805
10-K2017-03-09fiscal FY 2016281400001144204-17-013576
10-Q2016-11-03fiscal Q3 201625740001144204-16-131244
10-Q2016-08-04fiscal Q2 201625780001144204-16-116419
10-Q2016-05-10fiscal Q1 201619420001144204-16-100131
10-K2016-02-26fiscal FY 201527720001144204-16-084435
10-Q2015-10-22fiscal Q3 201523720001144204-15-060331
10-Q2015-08-10fiscal Q2 201523720001144204-15-047524
10-Q2015-04-20fiscal Q1 201518390001144204-15-023675
10-K2015-02-13fiscal FY 201426700001144204-15-008677
10-Q2014-10-15fiscal Q3 201424730001144204-14-061153
10-Q2014-07-16fiscal Q2 201424710001144204-14-043268
10-Q2014-05-08fiscal Q1 201422560001144204-14-028382
10-K2014-02-20fiscal FY 2013261020001144204-14-010710
10-Q2013-11-07fiscal Q3 201321740001144204-13-059431
10-Q2013-08-06fiscal Q2 201324900001144204-13-043143
10-Q2013-05-09fiscal Q1 201323620001144204-13-027228
10-K2013-03-14fiscal FY 201225900001144204-13-014934
10-Q2012-11-14fiscal Q3 201220760001144204-12-061961
10-Q/A2012-09-04fiscal Q2 201220760001144204-12-049401
10-Q2012-05-14fiscal Q1 201219540001144204-12-028409
10-K2012-03-06fiscal FY 201119720001144204-12-013127
10-Q2011-11-10fiscal Q3 201119710001144204-11-062858
10-Q/A2011-09-08fiscal Q2 201122810001144204-11-051767

Inspect the source

Entity
Aevi Genomic Medicine, Inc. / CIK 0001138776
Captured
SEC response SHA-256
16af7d8db7e8763eb25a11447dbdb1790b536242dd21d662c54ec3da77f91124

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001138776.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))